​FTC and seven states seek contempt ruling against Shkreli over pharma ban

Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions The Federal Trade Commission (FTC) and seven US states have alleged…

Source: The Guardian